Clinical Trials List
Protocol Number73763989HPB2004
Completed
2020-10-01 - 2025-12-31
Phase II
Recruiting2
ICD-10B17.0
Acute delta-(super) infection of hepatitis B carrier
ICD-9070.52
Hepatitis delta without mention of active hepatitis B disease without mention of hepatic coma
-
Trial Applicant
Johnson & Johnson
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Jee-Fu Huang Division of General Internal Medicine
- 黃駿逸 未分科
- Ming-Lun Yeh Division of General Internal Medicine
- 梁博程 Division of General Internal Medicine
- Chung-Feng Huang Division of General Internal Medicine
- Ming-Lung Yu Division of General Internal Medicine
- Chia-Yen Dai Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hung-Wei Wang 未分科
- Hung-Yao Chen 未分科
- Tsung-Yu Tsai 未分科
- Wei-Fan Hsu 未分科
- Hsueh-Chou Lai 未分科
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
50 participants
